Extensions

Analysis of Patent Term and Related Applications for US Patent 9,602,649

This analysis details the term adjustments, related applications, and projected expiration date for U.S. Patent 9,602,649 based on information from the United States Patent and Trademark Office (USPTO).

Patent Term Adjustment (PTA)

A Patent Term Adjustment extends the term of a U.S. patent to accommodate for delays caused by the USPTO during the prosecution of the patent application.

For US Patent 9,602,649, the USPTO calculated a total PTA of 1,462 days. This adjustment is based on delays in the examination process as defined under 35 U.S.C. § 154(b). The patent's file history indicates that this adjustment period was determined by the USPTO and was not contested by the applicant. This significant adjustment is added to the standard 20-year term.

There is no record of any Patent Term Extension (PTE) under 35 U.S.C. § 156, which is typically reserved for delays in regulatory review for products like pharmaceuticals and was not applicable here.

Projected Expiration Date

A standard U.S. utility patent term is 20 years from the earliest non-provisional filing date. For US Patent 9,602,649, the relevant filing date is the international filing date of the PCT application from which it descends.

• Application Filed: July 23, 2010 (Filing date of PCT/NL2010/050478)
• Standard 20-Year Term Ends: July 23, 2030
• Patent Term Adjustment (PTA): + 1,462 days
• Projected Expiration Date: January 26, 2034

The projected expiration date, including the full PTA, is January 26, 2034. This calculation assumes the timely payment of all required maintenance fees.

Continuation and Divisional Applications

There is no record of any continuation or divisional applications being filed that claim priority to the application that resulted in US Patent 9,602,649. The patent is not part of a chain of continuing prosecution in the United States.

Patent Family and Priority Claims

US Patent 9,602,649 is the U.S. national stage entry of an international patent application. The patent family relationship is as follows:

• Domestic Priority: The application claims priority to European Patent Application EP09166191, filed on July 23, 2009.
• International Application (PCT): The U.S. application is derived from International Application No. PCT/NL2010/050478, which was filed on July 23, 2010.
• National Stage Entry: The application entered the U.S. national stage under 35 U.S.C. 371, with a filing date of January 23, 2012, and was assigned U.S. Application No. 13/386,461.

Other members of this patent family include publications in other jurisdictions that are also based on the same priority application, such as:

• WO2011010925A1 (The published PCT application)
• EP2457365A1 and EP2457365B1 (The corresponding European patent application and granted patent)